Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE


E-pub date: 30 Apr 2019

Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.

E-pub date: 31 Aug 2018

Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.

E-pub date: 31 Jul 2018

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.

E-pub date: 31 Jan 2017

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.

E-pub date: 31 Dec 2015

Personalization of loco-regional care for primary breast cancer patients (part 1).

E-pub date: 31 Aug 2015

Personalization of loco-regional care for primary breast cancer patients (part 2).

E-pub date: 31 Aug 2015

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

E-pub date: 10 Jul 2015

Molecular changes in lobular breast cancers in response to endocrine therapy.

E-pub date: 01 Oct 2014

15p * molecular changes in lobular breast cancers in response to neoadjuvant letrozole.

E-pub date: 31 May 2014

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

E-pub date: 15 May 2014

Use of microarray analysis to investigate EMT gene signatures.

E-pub date: 31 Aug 2013

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation.

E-pub date: 31 Mar 2013

Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis.

E-pub date: 21 Aug 2012

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.

E-pub date: 15 Jun 2012

Initiating breast cancer by PIK3CA mutation.

E-pub date: 07 Feb 2012

Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole.

E-pub date: 01 Feb 2012

Understanding the mechanisms of aromatase inhibitor resistance.

E-pub date: 19 Jan 2012

Bridging the gap between translational research and clinical application.

E-pub date: 31 Aug 2011

Molecular effects of oestrogen deprivation in breast cancer.

E-pub date: 04 Jul 2011

Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole.

E-pub date: 31 Aug 2010

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.

E-pub date: 26 Aug 2010

Challenges in defining predictive markers for response to endocrine therapy in breast cancer.

E-pub date: 01 Nov 2009

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

E-pub date: 18 Aug 2009

Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.

E-pub date: 20 Mar 2009

Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors.

E-pub date: 01 Feb 2008

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole.

E-pub date: 31 Oct 2007

Aromatase inhibitors–gene discovery.

E-pub date: 31 Aug 2007

Molecular response to aromatase inhibitor treatment in primary breast cancer.

E-pub date: 31 Aug 2007

Aromatase in skeletal muscle.

E-pub date: 01 Mar 2003

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects.

E-pub date: 31 Oct 2002

Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues.

E-pub date: 01 May 2002

Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione.

E-pub date: 31 Jul 1998

Aromatase in breast cancer tissue–localization and relationship with reproductive status of patients.

E-pub date: 01 Aug 1996

Show all